Minireview: Nuclear insulin and insulin-like growth factor-1 receptors: A novel paradigm in signal transduction

Endocrinology

Volumn 154, Issue 5, 2013, Pages 1672-1679

  Sarfstein, Rive ^a   Werner, Haim ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; INSULIN; PROTEIN TYROSINE KINASE A; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

CELL NUCLEUS; CYTOPLASM; DNA BINDING; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMANS; INSULIN; MODELS, BIOLOGICAL; RATS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 84876753599     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-2165     Document Type: Review

References (41)

1. Yakar S, Pennisi P,KimCH,et al. Studies involving theGH-IGFaxis: lessons from IGF-1 and IGF-1 receptor gene targeting mouse models. J Endocrinol Invest. 2005;26:19-22.
2. Werner H, Weinstein D, Bentov I. Similarities and differences between insulin and IGF-1: structures, receptors, and signalling pathways. Arch Physiol Biochem. 2008;114:17-22.
3. Frasca F, Pandini G, Scalia P, et al. Insulin receptor isoform A, a newly recognized, high-Affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999;19:3278-3288.
4. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Rev. 2009;30:586-623.
5. Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H. Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer. Mol Cell Endocrinol. 2006;252:241-246.
6. LeRoith D, Accilli D. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nat Clin Pract Endocrinol Metab. 2008;4:164-172.
7. Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006; 7:85-96.
8. Federici M, Porzio O, Zucaro L, et al. Increased abundance of insulin/ IGF-1 hybrid receptors in adipose tissue from NIDDM patients. Mol Cell Endocrinol. 1997;135:41-47.
9. Bailyes EM, Nave BT, Soos MA, Orr SR, Hayward AC, Siddle K. Insulin receptor/IGF-1 receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem J. 1997;327(Pt 1):209-215.
10. Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-1), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst. 2002;94:972-980.
11. Werner H. Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer. Oncogene. 2012;31:2703-2714.
12. Sarfstein R, Belfiore A, Werner H. Identification of IGF-1R gene promoter binding proteins in estrogen receptor positive and ERdepleted breast cancer cells. Cancers (Basel). 2010;2:233-261.
13. Werner H, Karnieli E, Rauscher FJ III, LeRoith D. Wild type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA. 1996;93: 8318-8323.
14. Werner H, Bruchim I. IGF-1 and BRCA1 signalling pathways in familial cancer. Lancet Oncol. 2012;13:e537-e544.
15. Yuen JS, Cockman ME, Sullivan M, et al. The VHL tumor suppressor inhibits expression of the IGF1R and its loss induces IGF1R upregulation in human clear cell renal carcinoma. Oncogene. 2007; 26:6499-6508.
16. Boone DN, Lee AV. Targeting the insulin-like growth factor receptor: developing biomarkers from gene expression profiling. Crit Rev Oncog. 2012;17:161-173.
17. Goldfine ID, Smith GJ. Binding of insulin to isolated nuclei. Proc Natl Acad Sci USA. 1976;73:1427-1431.
18. Goldfine ID, Vigneri R, Cohen D, Pliam NB, Kahn CR. Intracellular binding sites for insulin are immunologically distinct from those on the plasma membrane. Nature. 1977;269:698-700.
19. Vigneri R, Goldfine ID,WongKY, Smith GJ, Pezzino V. The nuclear envelope. The major site of insulin binding in rat liver nuclei. J Biol Chem. 1978;253:2098-2103.
20. Horvat A. Insulin binding sites on rat liver nuclear membranes: biochemical and immunofluorescent studies. J Cell Physiol. 1978; 97:37-47.
21. Bergeron JJ, Posner BI, Josefsberg Z, Sikstrom R. Intracellular polypeptide hormone receptors. The demonstration of specific binding sites for insulin and human growth hormone in Golgi fractions isolated from the liver of female rats. J Biol Chem. 1978;253:4058-4066.
22. Podlecki DA, Smith RM, Kao M, et al. Nuclear translocation of the insulin receptor. A possible mediator of insulin's long term effects. J Biol Chem. 1987;262:3362-3368.
23. Chen CW, Oberley TD, Roy D. Inhibition of stilbene estrogen-induced cell proliferation of renal epithelial cells through the modulation of insulin-like growth factor-I receptor expression. Cancer Lett. 1996;105:51-59.
24. Sun H, Tu X, Prisco M, Wu A, Casiburi I, Baserga R. Insulin-like growth factor I receptor signaling and nuclear translocation of insulin receptor substrates 1 and 2. Mol Endocrinol. 2003;17:472-486.
25. Baserga R. The decline and fall of the IGF-1 receptor. J Cell Physiol. 2013;228:675-679.
26. Sarfstein R, Pasmanik-Chor M, Yeheskel A, et al. Insulin-like growth factor-I receptor (IGF-1R) translocates to nucleus and autoregulates IGF-1R gene expression in breast cancer cells. J Biol Chem. 2012;287:2766-2776.
27. Sehat B, Tofigh A, Lin Y, et al. SUMOylation mediates the nuclear translocation and signaling of the IGF-1 receptor. Sci Signal. 2010; 3:ra10.
28. Aleksic T, Chitnis MM, Perestenko OV, et al. Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells. Cancer Res. 2010;70:6412-6419.
29. Deng H, Lin Y, Badin M, et al. Over-Accumulation of nuclear IGF-1 receptor in tumor cells requires elevated expression of the receptor and the SUMO-conjugating enzyme Ubc9. Biochem Biophys Res Commun. 2011;404:667-671.
30. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol. 2003;23:3363-3372.
31. Sjostrom S, Warsito D, Larsson O, Sehat B. Mechanisms behind nuclear translocation of the IGF-1R. Growth Hormones IGF Res. 2012;22:536.
32. Warsito D, Sjostrom S, Andersson S, Larsson O, Sehat B. Nuclear IGF1R is a transcriptional co-Activator of LEF1/TCF. EMBO Rep. 2012;13:244-250.
33. Schlessinger J, Lemmon MA. Nuclear signaling by receptor tyrosine kinases: the first robin of spring. Cell. 2006;127:45-48.
34. Wang SE. The functional crosstalk between HER2 tyrosine kinase and TGF-beta signaling in breast cancer malignancy. J Signal Transduct. 2011;2011:804236.
35. Casaletto JB, McClatchey AI. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat Rev Cancer. 2012;12:387-400.
36. BrandTM,IidaM,Li C, Wheeler DL. The nuclear epidermal growth factor receptor signaling network and its role in cancer. DiscovMed. 2011;12:419-432.
37. Baron O, Forthmann B, Lee YW, et al. Cooperation of nuclear fibroblast growth factor receptor 1 and Nurr1 offers new interactive mechanism in postmitotic development of mesencephalic dopaminergic neurons. J Biol Chem. 2012;287:19827-19840.
38. Rakowicz-Szulczynska EM, Herlyn M, Koprowski H. Nerve growth factor receptors in chromatin of melanoma cells, proliferating melanocytes, and colorectal carcinoma cells in vitro. Cancer Res. 1988;48:7200-7206.
39. Matteucci E, Bendinelli P, Desiderio MA. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells. Carcinogenesis. 2009;30:937-945.
40. Asmane I, Watkin E, Alberti L, et al. Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas. Eur J Cancer. 2012;48:3027-3035.
41. Hoa N, Tsui S, Afifiyan NF, et al. Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Grave's disease: apparent role of ADAM17. Plos ONE. 2012;7(4):e34173.